Real-Life Efficacy and Safety of Vemurafenib Plus Rituximab (V+R) in Relapsed or Refractory Hairy Cell Leukemia: A Multi-Center Retrospective Study (HCL-PG03R)Enrico Tiacci,Luca De Carolis,Monia Capponi, Andrea Bernardelli,Andrea Visentin, Gianna Maria D'Elia,Simone Ferrero,Michele Cimminiello, Azzurra Anna Romeo, Barbara Pocali, Flavio Falcinelli,Alessandro Sanna, Annamaria Frustaci, Nilla Maschio,Caterina Stelitano,Jacopo Olivieri,Carlo Visco,Alessandro Pulsoni,Robin Foa,Livio TrentinBlood(2023)引用 0|浏览6暂无评分摘要BACKGROUND更多查看译文AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要